Industry News
How A Drug-Lead Compound Kills Cancer Cells By 'Starving' Them Of Energy, Preventing Tumor Formation
May 23, 2012
A team of scientists from the National University of Singapore's (NUS) Department of Biological Sciences and Mechanobiology Institute have discovered how a drug-lead compound - a compound that is undergoing preclinical trials as a potential drug - can deprive cancer cells of energy and stop them from growing into a tumour. This drug-lead compound is named BPTES... Read More
How A Drug-Lead Compound Kills Cancer Cells By 'Starving' Them Of Energy, Preventing Tumor Formation
May 23, 2012
A team of scientists from the National University of Singapore's (NUS) Department of Biological Sciences and Mechanobiology Institute have discovered how a drug-lead compound - a compound that is undergoing preclinical trials as a potential drug - can deprive cancer cells of energy and stop them from growing into a tumour. This drug-lead compound is named BPTES... Read More
Lung Cancer CT Screening Guidelines Revised
May 22, 2012
Older, current and former heavy smokers should receive annual, low-dose CT screening, according to revised guidelines published in the Journal of the American Medical Association on Sunday. The revised guidelines follow, and in the JAMA paper are accompanied by, a systematic review of evidence on the role of CT screening for individuals at higher risk of lung cancer... Read More
PSA Screening Benefits Few, Harms Many, Says Panel
May 22, 2012
A US government-sponsored panel of independent experts that reviews evidence and develops recommendations for preventive clinical services says the harms of PSA-based testing for prostate cancer outweigh the benefits. The recommendation has provoked a strong and angry response from many patient and medical groups... Read More
Task Force Recommends Against PSA-Based Screening For Prostate Cancer: Evidence Show Harms Of PSA Testing Outweigh The Benefits
May 22, 2012
Following a period for public comment, the United States Preventive Services Task Force (USPSTF) released its final recommendation for prostate cancer screening. The Task Force now recommends against PSA-based screening for all men, regardless of age... Read More
The Risk Of Lung Cancer Mortality In The Elderly Increased By Tuberculosis
May 22, 2012
Tuberculosis independently predicts death from lung cancer in the elderly, according to a new study from researchers in Hong Kong. "There is a high incidence of both tuberculosis and lung cancer among the elderly in Hong Kong," said lead author Chi Chiu Leung, MBBS, consultant chest physician in the Tuberculosis and Chest Service of the Department of Health of Hong Kong... Read More
Sleep Apnea Has Higher Risk Of Cancer Mortality
May 22, 2012
University of Wisconsin School of Medicine and Public Health released a study today showing that those suffering from sleep apnea appear to have an increased risk of cancer mortality. Previous studies have linked the sleep disordered breathing (SBD) problems to hypertension, cardiovascular disease, depression and earlier death, but this is the first to find a link to cancer... Read More
Statins Protect From Cancer In Heart Transplant Patients
May 22, 2012
Researchers presented a study at the Heart Failure Association of the European Society of Cardiology's 2012 Heart Failure Congress in Belgrade, Serbia, which revealed that statins are linked to preventing cancer and reduce all-cause mortality risk in heart transplant recipients independent of cholesterol levels. Statins are a class of immunomodulatory drugs used to lower cholesterol levels... Read More
Predicting Response To New Treatments In Colon Cancer
May 22, 2012
The Stem Cells and Cancer Research Group headed by Dr Hector G. Palmer at the Vall d'Hebron Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment... Read More
New Target Identified In The Rheumatoid Arthritis Battle
May 22, 2012
A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence that drugs under development for diseases such as cancer could potentially be used to treat RA... Read More
Previous Page Next Page